XSWX:KURN (Switzerland)  
Kuros Biosciences Ltd logo

Kuros Biosciences Ltd

CHF 1.63 (+5.16%) Oct 3
P/E:
At Loss
P/B:
0.73
Market Cap:
CHF 59.57M ($ 60.82M)
Enterprise V:
CHF 39.95M ($ 40.79M)
Volume:
9.83K
Avg Vol (2M):
12.69K
Also Trade In:
Volume:
9.83K
Market Cap CHF:
59.57M
Market Cap $:
60.82M
PE Ratio:
At Loss
Avg Vol (2-Month):
12.69K
Enterprise Value CHF:
39.95M
Enterprise Value $:
40.79M
PB Ratio:
0.73
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Kuros Biosciences Ltd is a biotechnology company that focuses on the discovery, development and prospective commercialization of a new class of bio-pharmaceutical products for use in the treatment and prevention of chronic diseases. The company is also developing a family of bone healing products to address indications in trauma, and spine as well as sealants which provides reliable closure of tissue membranes to ensure functional integrity after surgery or trauma. The pipeline products of the company are Synthetic Orthobiologics, Fibrin Orthobiologics, and Sealants. The majority of the company's revenue comes from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 11.11
Equity-to-Asset 0.83
Debt-to-Equity 0.03
Debt-to-EBITDA -0.35
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.96
Distress
Grey
Safe
Beneish M-Score -1.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.02
9-Day RSI 43.32
14-Day RSI 43.83
6-1 Month Momentum % -13.09
12-1 Month Momentum % -29.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.43
Quick Ratio 2.25
Cash Ratio 1.62
Days Inventory 179.12
Days Sales Outstanding 86.7
Days Payable 77.39

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.9

Financials

XSWX:KURN's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 15.155
EPS (TTM) (CHF) -0.337
Beta 0.74
Volatility % 24.65
14-Day RSI 43.83
14-Day ATR (CHF) 0.119662
20-Day SMA (CHF) 1.70375
12-1 Month Momentum % -29.66
52-Week Range (CHF) 1.45 - 2.4
Shares Outstanding (Mil) 36.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kuros Biosciences Ltd Filings

Document Form Filing Date
No Filing Data

Kuros Biosciences Ltd Analysis

Share your research